IgG and Fc Receptor Genetic Variation Associates With Functional Antibody Responses in HVTN 108
Background: The HVTN108 trial evaluated the immunogenicity of a DNA prime, adjuvanted protein boost vaccine regimen in the US and South Africa. We defined the IgG antibody Fc and Fc receptor (FcR) genotypes in the study population to test our hypothesis that IgG and FcR genetic variation can affect vaccine-elicited functional antibody responses. Methods: HVTN108…